Docetaxel chemical structure

Find information on thousands of medical conditions and prescription drugs.

Taxotere

Docetaxel is a chemotherapy drug used in the treatment of cancer. It has been developed after the related drug, paclitaxel. It is derived from a species of yew, Taxus baccata. Together with paclitaxel, it forms the drug category of the taxanes.

It is mainly used in lung cancer, breast cancer, as well as in prostate cancer.

It is marketed as Taxotere in the U.S.

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

Oxytetracycline

Thiopental sodium

Tranexamic acid

Tranylcypromine

Triamcinolone hexacetonide

Triclabendazole

Trifluoperazine

Tubocurarine chloride

U

V

W

X

Y

Z

Read more at Wikipedia.org

• [List your site here Free!]


		Taxotere (with prednisone).(NEW & APPROVED) : An article from: Internal Medicine News $5.95			Taxotere, Enjuvia.(New & Approved) : An article from: Skin & Allergy News $5.95


	Xeloda/Taxotere breast cancer therapy gets FDA endorsement - Roche, Aventis - Brief Article Xeloda/Taxotere breast cancer therapy gets FDA endorsement.(Roche, Aventis) From Drug Store News, 10/8/01

	Drug combination approved for advanced breast cancer - Updates - Xeloda and Taxotere - Brief Article Two drugs already on the market to treat breast cancer have been approved by the FDA to be used in combination for an even greater effect in treating ... From FDA Consumer, 1/1/02

	Pharmaceutical: top 50 packages PHARMACEUTICAL From Food & Drug Packaging, 7/1/05

	Gpc Biotech Presents New Satraplatin Data At Aacr GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; NASDAQ: GPCB) has announced that the company presented data on its lead drug candidate satraplatin at the 96th Annual Meeting of the Ame From Worldwide Biotech, 6/1/05

	The war on cancer Provenge for Prostate Cancer Prostate cancer is one of the most common cancers. Each year in the US, around 230,000 men are newly diagnosed with prostate ... From Townsend Letter for Doctors and Patients, 6/1/05 by Ralph W. Moss

	Clinical trial of Iressa In December 2004, the FDA learned from AstraZeneca Pharmaceuticals that a large clinical trial comparing Iressa (gefitinib) with an inactive substance ... From FDA Consumer, 3/1/05

	New indication for docetaxel Taxotere (docetaxel) concentrate for injection, in combination with doxorubicin and cyclophosphamide, is indicated for the adjuvant treatment of operable ... From OB/GYN News, 12/1/04

	Interim Analysis of Phase III Study Shows TAXOTERE®-Based Regimens With HERCEPTIN® Significantly Improved Disease Free Survival in Women With Results from the BCIRG 006 study also show that a novel non-anthracycline-based regimen ("TCH") with TAXOTERE(R) (docetaxel), the platinum ... From PR Newswire, 12/8/05

Home

Contact

Resources

ebay